Handelsbanken Fonder AB Has $425.44 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Handelsbanken Fonder AB reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 7.3% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 812,296 shares of the healthcare conglomerate's stock after selling 64,052 shares during the quarter. UnitedHealth Group makes up approximately 1.8% of Handelsbanken Fonder AB's portfolio, making the stock its 9th largest position. Handelsbanken Fonder AB owned about 0.09% of UnitedHealth Group worth $425,440,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of the company. Petredis Investment Advisors LLC boosted its holdings in UnitedHealth Group by 2.0% in the 1st quarter. Petredis Investment Advisors LLC now owns 31,306 shares of the healthcare conglomerate's stock valued at $16,397,000 after purchasing an additional 621 shares during the period. Central Valley Advisors LLC boosted its stake in UnitedHealth Group by 6.2% in the first quarter. Central Valley Advisors LLC now owns 3,968 shares of the healthcare conglomerate's stock valued at $2,078,000 after acquiring an additional 232 shares during the last quarter. Curated Wealth Partners LLC increased its holdings in UnitedHealth Group by 52.9% in the first quarter. Curated Wealth Partners LLC now owns 786 shares of the healthcare conglomerate's stock valued at $412,000 after purchasing an additional 272 shares during the last quarter. Dividend Assets Capital LLC raised its stake in UnitedHealth Group by 8.3% during the 1st quarter. Dividend Assets Capital LLC now owns 24,338 shares of the healthcare conglomerate's stock worth $12,747,000 after buying an additional 1,875 shares during the period. Finally, Walker Asset Management LLC raised its position in shares of UnitedHealth Group by 4.5% during the first quarter. Walker Asset Management LLC now owns 654 shares of the healthcare conglomerate's stock worth $342,000 after purchasing an additional 28 shares during the period. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, CFO John F. Rex bought 17,175 shares of UnitedHealth Group stock in a transaction dated Friday, May 16th. The stock was acquired at an average cost of $291.12 per share, with a total value of $4,999,986.00. Following the completion of the acquisition, the chief financial officer now owns 203,796 shares of the company's stock, valued at approximately $59,329,091.52. This represents a 9.20% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Timothy Patrick Flynn purchased 1,533 shares of the firm's stock in a transaction that occurred on Wednesday, May 14th. The shares were bought at an average cost of $320.80 per share, with a total value of $491,786.40. Following the completion of the acquisition, the director now owns 6,033 shares of the company's stock, valued at approximately $1,935,386.40. This trade represents a 34.07% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last quarter, insiders bought 109,408 shares of company stock worth $31,607,768. Company insiders own 0.28% of the company's stock.

UnitedHealth Group Price Performance

Shares of UNH traded up $5.13 during mid-day trading on Wednesday, reaching $308.92. The stock had a trading volume of 8,302,867 shares, compared to its average volume of 7,068,435. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a 12 month low of $248.88 and a 12 month high of $630.73. The business has a fifty day moving average of $399.88 and a 200 day moving average of $479.36. The firm has a market cap of $280.23 billion, a price-to-earnings ratio of 19.91, a PEG ratio of 1.37 and a beta of 0.45.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. During the same quarter in the prior year, the company posted $6.91 EPS. Equities analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th will be given a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.86%. The ex-dividend date of this dividend is Monday, June 16th. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's payout ratio is 37.02%.

Analysts Set New Price Targets

Several research firms have commented on UNH. Truist Financial restated a "buy" rating and issued a $360.00 target price (down previously from $580.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. Wolfe Research dropped their price target on UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating for the company in a report on Tuesday, May 20th. Barclays lowered their price objective on UnitedHealth Group to $350.00 and set an "overweight" rating on the stock in a research note on Monday, June 2nd. KeyCorp reduced their price objective on UnitedHealth Group from $450.00 to $400.00 and set an "overweight" rating on the stock in a research report on Monday, June 2nd. Finally, Oppenheimer cut their price target on UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating for the company in a research note on Wednesday, May 14th. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and sixteen have given a buy rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $426.52.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.